Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00592982 · ClinicalTrials.gov registry record
Bisphosphonate-Associated Jaw Osteonecrosis and PET Imaging
A clinical trial of Bisphosphonate-associated ONJ and Osteomyelitis of the Jaw, sponsored by University of Arkansas.
- Completed
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT00592982 is a study of Bisphosphonate-associated ONJ and Osteomyelitis of the Jaw that has completed, run by University of Arkansas. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00592982, a study of Bisphosphonate-associated ONJ and Osteomyelitis of the Jaw, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
1. Bisphosphonate-associated osteonecrosis of the jaw(ONJ)is detectable by positron emission tomography(PET). 2. Bisphosphonate-associated ONJ can be diagnosed and characteristically differentiated from other bony pathologies of the jaw(osteomyelitis, osteolytic lesions, and osteoradionecrosis)by PET imaging.
Conditions Studied
Study Locations (1)
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2006-10 |
| Est. Completion | 2013-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00592982
The ClinicalTrials.gov registry entry for NCT00592982 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Bisphosphonate-associated ONJ appearing as the primary indexed condition, and to 0 interventions.
NCT00592982 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.
Frequently Asked Questions
What is clinical trial NCT00592982 about?
NCT00592982 is a clinical study titled "Bisphosphonate-Associated Jaw Osteonecrosis and PET Imaging". 1. Bisphosphonate-associated osteonecrosis of the jaw(ONJ)is detectable by positron emission tomography(PET). 2. Bisphosphonate-associated ONJ can be diagnosed and characteristically differentiated from other bony pathologies of the jaw(osteomyelitis, osteolytic lesions, and osteoradionecrosis)by PE...
What is the current status of trial NCT00592982?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2006-10. Estimated completion is 2013-08.
What conditions does trial NCT00592982 study?
This clinical trial studies the following conditions: Bisphosphonate-associated ONJ, Osteomyelitis of the Jaw, Osteolytic Lesions of the Jaw, Osteoradionecrosis of the Jaw.
Who is sponsoring clinical trial NCT00592982?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00592982 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.